 - Subjects with advanced, histologically or cytologically confirmed solid tumors, refractory to any standard therapy, have no standard therapy available, or subjects must have actively refused any treatment which would be regarded standard, and or if in the judgment of the investigator, experimental treatment is clinically and ethically acceptable 